Page 18 - Read Online
P. 18

Ashdown. J Cancer Metastasis Treat 2022;8:6                        Journal of Cancer
               DOI: 10.20517/2394-4722.2022.01
                                                                       Metastasis and Treatment




               Opinion                                                                       Open Access



               Tricking the tumour microenvironment into
               becoming our best rational drug design factory:

               reversal of immune suppression


               Martin L. Ashdown
               Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne 3011, Australia.
               Correspondence to: Martin L. Ashdown, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne,
               Melbourne 3011, Australia. E-mail: ashdownm@unimelb.edu.au

               How to cite this article: Ashdown ML. Tricking the tumour microenvironment into becoming our best rational drug design
               factory: reversal of immune suppression. J Cancer Metastasis Treat 2022;8:6. https://dx.doi.org/10.20517/2394-4722.2022.01

               Received: 4 Jan 2022  First Decision: 10 Feb 2022  Revised: 17 Feb 2022  Accepted: 21 Feb 2022  Published: 28 Feb 2022
               Academic Editors: Lucio Miele, Steven Fiering  Copy Editor: Xi-Jun Chen  Production Editor: Xi-Jun Chen


               Abstract
               The immune cellular components of the tumour microenvironment are a diverse group of cells that paradoxically
               are now appreciated to have a coordinated opposing duality of either promoting or retarding tumour growth.
               Manipulating this seemingly dynamic interaction for therapeutic benefit is a hotbed of much research. Recent
               findings in tumour immunology (both preclinical and clinical) build on more than a century of insights and provide a
               way forward to improving patient outcomes, long term survival and the predictability of “cures”. This opinion piece
               attempts to summarise some of these historical and contemporary insights with a view to describing eminently
               testable therapeutic solutions.
               Keywords: Tumour microenvironments, immune suppression, regulatory T cells, immune modulation, reversal,
               plasticity, spatio-temporal



               INTRODUCTION
               In 1926, Morris Fishbein, MD, the editor of the Journal of The American Medical Association (JAMA),
               wrote, “Cancers must be treated early, once a cancer has spread to surrounding tissue all attempts to halt the
                                      [1]
               disease are usually hopeless” .






                           © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                           www.jcmtjournal.com
   13   14   15   16   17   18   19   20   21   22   23